Q4 2015 13F Holders as of 12/31/2015
-
Type / Class
-
Equity / Common Stock, $0.00000002 par value
-
Shares outstanding
-
29.5M
-
Number of holders
-
37
-
Total 13F shares, excl. options
-
6.6M
-
Shares change
-
+367K
-
Total reported value, excl. options
-
$10.6M
-
Value change
-
+$592K
-
Put/Call ratio
-
1.05
-
Number of buys
-
20
-
Number of sells
-
-14
-
Price
-
$1.60
Significant Holders of MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP) as of Q4 2015
42 filings reported holding MEIP - MEI Pharma, Inc. - Common Stock, $0.00000002 par value as of Q4 2015.
MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP) has 37 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.6M shares
of 29.5M outstanding shares and own 22.34% of the company stock.
Largest 10 shareholders include Frigate Ventures LP (1.94M shares), VANGUARD GROUP INC (990K shares), Ancora Advisors, LLC (475K shares), BlackRock Institutional Trust Company, N.A. (423K shares), Connor, Clark & Lunn Investment Management Ltd. (405K shares), BRIDGEWAY CAPITAL MANAGEMENT INC (390K shares), FMR LLC (335K shares), RENAISSANCE TECHNOLOGIES LLC (275K shares), WASATCH ADVISORS INC (262K shares), and SABBY MANAGEMENT, LLC (200K shares).
This table shows the top 37 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.